C. difficile samples being studied within the Sorg Lab.

Texas A&M-Led Research Rules Out Secondary Bile Acids as Protector Against C Diff

Nov 29, 2021
“Many ongoing efforts are developing probiotic treatment options for C. diff-infected patients — efforts that focus on restoring secondary bile acids to patients. Our findings show that these treatments should instead focus on microbes that consume nutrients important for C. diff growth and that secondary bile acids are a red herring for protection.”
Dr. Joseph Sorg, Texas A&M biologist